Free Trial

Bicara Therapeutics (BCAX) SEC Filings & 10K Form

Bicara Therapeutics logo
$16.92 +0.47 (+2.86%)
Closing price 10/23/2025 04:00 PM Eastern
Extended Trading
$17.50 +0.58 (+3.42%)
As of 10/23/2025 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Bicara Therapeutics SEC Filings

DateFilerForm TypeView
10/16/2025
3:41 PM
Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2025
3:13 PM
Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025
5:00 PM
Bicara Therapeutics (Issuer)
Mazumdar Claire (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2025
3:18 PM
Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025
3:20 PM
Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2025
8:05 AM
Bicara Therapeutics (Subject)
Mazumdar Claire (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2025
4:22 PM
Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2025
4:23 PM
Bicara Therapeutics (Issuer)
Raben David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2025
3:31 PM
Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2025
4:33 PM
Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2025
4:33 PM
Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2025
3:04 PM
Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2025
3:20 PM
Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2025
3:07 PM
Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2025
3:36 PM
Bicara Therapeutics (Subject)
Cohlhepp Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2025
3:07 PM
Bicara Therapeutics (Subject)
Hyep Ivan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2025
3:38 PM
Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2025
4:01 PM
Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
6:41 AM
Bicara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2025
1:56 PM
Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
Form SCHEDULE 13G/A
07/17/2025
10:08 AM
Bicara Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
07/17/2025
10:11 AM
Bicara Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
06/18/2025
4:12 PM
Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:33 PM
Bicara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
3:34 PM
Bicara Therapeutics (Issuer)
RA Capital Nexus Fund III, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:37 PM
Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:26 PM
Bicara Therapeutics (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:27 PM
Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:28 PM
Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
6:43 AM
Bicara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
8:12 AM
Bicara Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/27/2025
6:45 AM
Bicara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
5:35 PM
Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:21 PM
Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
8:14 AM
Bicara Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G
01/13/2025
7:02 AM
Bicara Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCAX) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners